Gong, Tianqi
Lao, I. Weng
Chio, Chan Fong
Zhang, Xiaowei
Ren, Min
Li, Weiwei
Qu, Ning
Ni, Xiaotian
Gong, Tongqing
Gu, Yanzi
Qin, Guangqi
Yang, Xiaoqun
Deng, Yu
Xu, Yan
Liu, Zebing
Tao, Kun
Hou, Yingyong
Wong, Sio In
Wang, Qifeng
Wang, Wenfeng
Wang, Jian
Li, Yuan
Qin, Wenxing
Luo, Zhiguo
Zhou, Xiaoyan
Qin, Jun
Xu, Midie
Funding for this research was provided by:
National Natural Science Foundation of China (82272626)
National Natural Science Foundation of China (82573699)
Innovation Program of STCSM Shanghai Science and Technology Committee (20Z11900300)
Shanghai Clinical Research Project of Shanghai Shenkang Hospital Development Center (SHDC2020CR4068)
Beijing Xisike Clinical Oncology Research Foundation (Young2023-0023)
Article History
Received: 1 September 2025
Accepted: 25 December 2025
First Online: 9 January 2026
Declarations
:
: Ethical approval and consent to participate in the study were obtained from the Clinical Research Ethics Committee of the Fudan University Shanghai Cancer Center (FUSCC) (Ethical code: 2012228-Exp10 and 2309282-22) and the Ethics Committee of the Conde de São Januário Hospital (Ethical code: 0053/MEC/N/2024).
: Consent for publish has been obtained from the participant.
: The authors declare no competing interests.